Carmoterol was being developed by the licensee company Chiesi in clinical trials as a once-daily therapy for chronic obstructive pulmonary disease. It is a non-catechol. Reference standards of Carmoterol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Carmoterol-d3 Hydrochloride [catalogue_number] => PA STI 018060 [category_ids] => ,80,69,71,78,70,82,98, [chemical_name] => [weight] => 407.91 [form] => C21H22D3ClN2O4 [cas] => 1276319-69-7 [pslug] => 1276319-69-7-carmoterol-d3-hydrochloride-pasti018060 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 018060
CAS :
Molecular Formula : C21H22D3ClN2O4
Molecular Weight : 407.91
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
